D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Home BancShares
HOMB
$6.21B
| $315K | ﹤0.01% |
+18,570
| New | +$294K |
|
3252
Xcel Energy
XEL
$51B
| $315K | ﹤0.01% |
9,056
-47,327
| -84% | -$1.69M |
|
|
KBAL
3253
DELISTED
Kimball International
KBAL
| $315K | ﹤0.01% |
30,096
+12,822
| +74% | +$122K |
|
3254
Scansource
SCSC
$1.12B
| $314K | ﹤0.01% |
7,730
-7,814
| -50% | -$296K |
|
|
ADNC
3255
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
| $314K | ﹤0.01% |
69,237
+44,847
| +184% | +$204K |
|
3256
Stoneridge
SRI
$209M
| $312K | ﹤0.01% |
27,667
+12,697
| +85% | +$153K |
|
|
GOLD
3257
DELISTED
Randgold Resources Ltd
GOLD
| $312K | ﹤0.01% |
+4,530
| New | +$340K |
|
3258
Huntington Bancshares
HBAN
$35.1B
| $310K | ﹤0.01% |
+28,075
| New | +$296K |
|
|
ARRY
3259
DELISTED
Array Biopharma Inc
ARRY
| $308K | ﹤0.01% |
41,750
-313,319
| -88% | -$2.23M |
|
|
SCNB
3260
DELISTED
Suffolk Bancorp
SCNB
| $308K | ﹤0.01% |
12,953
+2,297
| +22% | +$52K |
|
|
NFBK
3261
DELISTED
Northfield Bancorp
NFBK
| $306K | ﹤0.01% |
+20,655
| New | +$300K |
|
|
CLD
3262
PUT
DELISTED
Cloud Peak Energy Inc
CLD
| $306K | ﹤0.01% |
52,500
-40,000
| -43% | -$295K |
|
3263
Lincoln National
LNC
$7.91B
| $305K | ﹤0.01% |
5,315
-39,041
| -88% | -$2.18M |
|
|
CRR
3264
CALL
DELISTED
Carbo Ceramics Inc.
CRR
| $305K | ﹤0.01% |
10,000
-58,700
| -85% | -$2.06M |
|
3265
ASML
ASML
$675B
| $304K | ﹤0.01% |
3,005
-11,178
| -79% | -$1.17M |
|
|
NAV
3266
DELISTED
Navistar International
NAV
| $304K | ﹤0.01% |
10,322
-57,638
| -85% | -$1.73M |
|
|
CRC
3267
PUT
DELISTED
California Resources Corporation
CRC
| $304K | ﹤0.01% |
4,000
-11,872
| -75% | -$726K |
|
|
NBIS
3268
CALL
Nebius Group N.V.
NBIS
$47.7B
| $303K | ﹤0.01% |
20,000
-134,700
| -87% | -$2.17M |
|
3269
Materion
MTRN
$5.01B
| $302K | ﹤0.01% |
7,867
-20,910
| -73% | -$751K |
|
3270
Waters Corp
WAT
$36.8B
| $302K | ﹤0.01% |
2,433
-79,456
| -97% | -$9.48M |
|
|
PRAH
3271
DELISTED
PRA Health Sciences, Inc.
PRAH
| $302K | ﹤0.01% |
+10,462
| New | +$292K |
|
3272
Middlesex Water
MSEX
$1.05B
| $301K | ﹤0.01% |
+13,210
| New | +$295K |
|
|
DANG
3273
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $301K | ﹤0.01% |
31,566
-24,927
| -44% | -$219K |
|
3274
Winmark
WINA
$1.19B
| $300K | ﹤0.01% |
3,425
+683
| +25% | +$56K |
|
|
TTPH
3275
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $300K | ﹤0.01% |
+410
| New | +$308K |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.